Table 1. Demonstration models.
Name |
Description |
Simple
reaction |
Conversion
of a A to B |
Simple
enzymatic reaction |
Substrate
to product conversion by an enzyme |
Bistable |
A
network that shows bistability due to positive feedback between MAPK, PLA2
and PKC.(1) |
cAMP |
Ligand
activation of the cAMP cascade and PKA.(2) |
Chemotaxis |
Phosphorelay
cascade that controls the rapid chemotactic response in E.coli to the
attractant aspartate and the repellent Ni2+ ions.(3) |
CamKII |
Activation
of calcium/calmodulin-dependent protein kinase II (CaMKII) by calmodulin
following calcium entry into the cell.(4) |
G
protein activation |
Generic
G-protein coupled receptor signalling model that looks at the kinetics of the
G protein activation and receptor phosphorylation(5, 6) |
MAPK-EGFR |
EGFR
stimulated activation of MAPK and subsequent inactivation of EGFR input(1) |
MAPK
oscillations |
Oscillations
in the mitogen-activated protein kinase (MAPK) cascades due to negative
feedback loop combined with intrinsic ultrasensitivity of the MAPK cascade(7) |
nNOS |
Catalysis
and activation in neuronal nitric Oxide Synthase (nNOS) and in its
interaction with CaMCa4(8) |
RanGTPase |
Kinetics
of the RanGTPase system involved in receptor-mediated nuclear transport(9) |
Ras |
Ras
GTPase activation by GTPase Activating Proteins (10, 11) |
Repressilator |
Artificial
network of transcription regulators in E.coli which results in sustained
oscillations (12) |
MATERIALS
1. GENESIS/Kinetikit
software, included in download. Approximately 1.5 MB download and 4 MB
uncompressed.
2. Set of simulation models
in GENESIS (.g) format, a sample of which come with the download.
3. Optional:
Additional simulation models. May be downloaded from the
databases DOQCS (http://doqcs.ncbs.res.in)
and SIGPATH (http://icb.med.cornell.edu/crt/SigPath/index.xml)
EQUIPMENT
PC with Linux operating system (Kernel 2.4 or later, e.g., Red Hat
Linux 7.2 and higher).
INSTRUCTIONS
Installing the software.
tar xzf kkitdemo.tgz
This will produce a
directory named kinetic_demo. These steps are sufficient for running the
demonstration simulations.
Running demos
./demo
Several model schematics
will flash past as the system loads the models.
Stochastic
simulations.
Beyond demos: Modifying and manually running a
model.
genesis modelname.g
It will load up the model and you can edit it and run it in the regular
way. Predefined stimulus inputs will not work in such cases.
genesis –nox modelname.g
This mode still allows fully interactive text control of the simulation
using the scripting language. The next level of automation is to run it
completely without supervision using a model file that specifies everything including
model, inputs, and outputs:
genesis –nox –notty modelname.g
This mode is used for example, in running simulations in parallel on a
computing cluster.
genesis models/EGFR_MAPK.g
This creates the EGFR_MAPK model, which
itself is rather large. This model has a fixed value of PKA as a regulatory
input. Now from the genesis prompt type:
include models/cAMP.g
This loads in the activation stages for PKA, and will result in a large
composite model including all the represented pathways. Now the PKA activity is
no longer fixed, but is in turn a function of G-protein activity. The composite
MAPK activity is a function now both of EGF and G-protein coupled receptor
inputs. The composite model can be edited and saved in the usual way.
Installing
for heavy use.
cp kinetic_demo/.simrc&nsbp; ~
Edit it so that the paths following the SIMPATH and GENESIS_HELP fields
are set to refer to your installation directory. Note that the preceding period
in the name .simrc will make the file invisible to the usual Unix directory listing
command ls.
These changes will enable kinetikit to be run
from any directory by typing
genesis kkit
or
genesis modelname
REFERENCES
1. U.
S. Bhalla, R. Iyengar, Science 283,
381-387 (1999).
2. U.
S. Bhalla, in Methods in Enzymology
J. D. Hildebrandt, R. Iyengar, Eds. (Academic Press, 2002), vol. 345, pp. 3-23.
3. D.
Bray, R. B. Bourret, M. I. Simon, Mol
Biol Cell 4, 469-82 (May, 1993).
4. W.
R. Holmes, J. Comput. Neurosci. 8,
65-85 (2000).
5. L.
D. Shea, R. R. Neubig, J. J. Linderman, Life
Sci 68, 647-58 (Dec 29, 2000).
6. P.
J. Woolf, J. J. Linderman, Biophys J
84, 3-13 (Jan, 2003).
7. B.
N. Kholodenko, Eur J Biochem 267,
1583-1588 (2000).
8. J.
Santolini, S. Adak, C. M. Curran, D. J. Stuehr, J Biol Chem 276, 1233-43 (Jan 12, 2001).
9. D.
Gorlich, M. J. Seewald, K. Ribbeck, Embo
J 22, 1088-100 (Mar 3, 2003).
10. R.
A. Phillips, J. L. Hunter, J. F. Eccleston, M. R. Webb, Biochemistry 42, 3956-65 (Apr 8, 2003).
11. S.
E. Neal, J. F. Eccleston, A. Hall, M. R. Webb, J Biol Chem 263, 19718-22 (Dec 25, 1988).
12. M.
B. Elowitz, S. Leibler, Nature 403,
335-8 (Jan 20, 2000).